2 results  1 of 1 

1 Cerebrospinal Biomarker Cut-off Methods Defined Only by Alzheimer's Disease Predict More Precisely Conversions of Mild Cognitive Impairment
Jong Hun Kim, Hyunsun Lim, Jee-un Lee, Jeong Hee Cho, Gyu Sik Kim, Seong Hye Choi, Jun Hong Lee,
Dement Neurocogn Disord.2017;16(4):114-120.   Published online 2017 December 31     DOI: http://dx.doi.org/10.12779/dnd.2017.16.4.114
      
2 Role of Cerebrospinal Fluid Biomarkers in Clinical Trials for Alzheimer's Disease Modifying Therapies
Ju-Hee Kang, Na-Young Ryoo, Dong Wun Shin, John Q Trojanowski, Leslie M. Shaw
Korean J Physiol Pharmacol.2014;18(6):447-456.   Published online 2014 December 30     DOI: http://dx.doi.org/10.4196/kjpp.2014.18.6.447
      

 1 of 1